Rigel Pharmaceuticals, Inc. (RIGL) Social Stream



Rigel Pharmaceuticals, Inc. (RIGL): $1.80

-0.07 (-3.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RIGEL PHARMACEUTICALS INC (RIGL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RIGL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 4 $11 $7 $8.5 $1.91 345.03%
2022-03-02 4 $11 $7 $8.25 $1.91 331.94%
2022-05-03 5 $11 $4 $7.4 $1.91 287.43%
2022-05-05 5 $11 $4 $7.2 $1.91 276.96%
2022-06-09 7 $7 $0.8 $2.008 $1.91 5.13%
2022-07-25 7 $7 $0.8 $2.15 $1.91 12.57%
2022-08-03 7 $7 $0.8 $2.392 $1.91 25.24%
2022-10-11 7 $15 $0.8 $3.678 $1.91 92.57%
2022-11-06 7 $15 $0.8 $3.535 $1.91 85.08%
2022-12-02 7 $15 $0.8 $3.478 $1.91 82.09%
2023-01-11 7 $15 $0.8 $3.492 $1.91 82.83%

The Trend in the Analyst Price Target


RIGL's average price target has moved down $5.01 over the prior 14 months.

Over the past 45 weeks, RIGL's average upside potential has been 216.25%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-23 5 11 4.0 7.400 3.09 139.48%
2022-05-05 5 11 4.0 7.200 2.42 197.52%
2022-07-25 7 7 0.8 2.150 1.19 80.67%
2022-08-03 7 7 0.8 2.392 1.41 69.65%
2022-12-05 7 15 0.8 3.492 0.95 267.58%

RIGL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.14 3 0 4 0 0 7

The Trend in the Broker Recommendations


Over the past 44 weeks, RIGL's average broker recommendation rating worsened by 0.74.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, RIGEL PHARMACEUTICALS INC's average analyst price target is higher than 58.78% of them.
  • In terms of how RIGEL PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -968.37% of that group.
  • RIGEL PHARMACEUTICALS INC's number of analysts covering the stock is higher than 988.95% of stocks in the small market cap category.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, RIGEL PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 709.2% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to RIGEL PHARMACEUTICALS INC are ANIP, SEEL, and SIGA.

Is RIGL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.798 seconds.